Oncolys BioPharma's IPO

Oncolys BioPharma raised a round of funding on December 09, 2013. Investors include Public.

Oncolys BioPharma develops breakthrough therapy and diagnostics in cancer treatment from early to late stage, including early detection, loco-regional therapy, prognostic test, and systemic treatments…

Articles about Oncolys BioPharma's IPO: